共 50 条
- [21] DOPAMINE AGONISTS AND DYSKINESIA IN ADVANCED PARKINSON'S DISEASE: A NETWORK META-ANALYSIS OF ROTIGOTINE, PRAMIPEXOLE AND ROPINIROLE AS ADJUNCT THERAPY TO LEVODOPA[J]. VALUE IN HEALTH, 2012, 15 (04) : A141 - A141Senior, E.Dedeken, P.Naci, H.
- [22] Dopamine agonists and dyskinesia in advanced Parkinson's disease: A network meta-analysis of rotigotine, pramipexole and ropinirole as adjunct therapy to levodopa[J]. MOVEMENT DISORDERS, 2012, 27 : S138 - S138Senior, E.Dedeken, P.Naci, H.
- [23] Piribedil as an adjunct to levodopa in advanced Parkinson's disease: the Asian experience[J]. PARKINSONISM & RELATED DISORDERS, 2003, 10 (02) : 117 - 121Evidente, VGHEsteban, RPDomingo, FMCarbajal, LOParazo, MA
- [24] Ropinirole as an adjunct to levodopa in the treatment of Parkinson's disease A short commentary[J]. Journal of Neurology, 2003, 250 : 97 - 97N. P. Quinn
- [25] Mucuna pruriens as adjunct therapy to levodopa in advanced Parkinson's disease[J]. REVISTA MEXICANA DE NEUROCIENCIA, 2021, 22 (05): : 180 - 183Botello-Villagrana, FernandoMartinez-Ramirez, Daniel
- [27] Prescription and utilization patterns of adjunct treatments to levodopa in Parkinson's disease[J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 : S224 - S224Saragoussi, DelphineRive, BenoitMilea, DominiqueToumi, MondherFantino, BrunoVerpillat, Patrice
- [29] Parkinson's Disease Effectiveness of Opicapon as a Supplement to Levodopa[J]. FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2016, 84 (04) : 188 - 188Lichert, Frank
- [30] Cost-effectiveness analysis of pramipexole in early Parkinson's disease[J]. VALUE IN HEALTH, 2003, 6 (03) : 274 - 274Noyes, KDick, AWHolloway, RG